News | SK Capital

All News

Uncategorized

Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio

May 5, 2025

Uncategorized

Carlyle and SK Capital Partners Announce Extension of bluebird bio Tender Offer to May 12, 2025

May 2, 2025

SK Capital

SK Capital Partners Appoints John Novak as Head of Business Development

April 16, 2025

Spectrum

Spectrum Vascular Welcomes New Executive Leadership

April 14, 2025

Florachem

SK Capital Partners Completes the Sale of Florachem to Tradebe Life Sciences

April 9, 2025

Acquisitions

SK Capital Makes Strategic Investment in Spectrum Vascular

March 31, 2025

Load More